Capvizr
News · All summaries
Healthcare & Life Sciences
RQ Bio
Series A$115 million
RoundSeries A
Amount$115 million
LeadFrazier Life Sciences
DateJune 25, 2026
THE DEAL, AT A GLANCE

RQ Bio

From the announcement
Who is involvedBacked by Frazier Life Sciences, new, EQT Life Sciences, ForbionFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedRQ Bio raised $115M Series A, announced 2026-06-25From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersRQ Bio's $115M Series A is a capital-flow signal in an active Digital Health funding window, with round size placing the company above most tracked sector financings…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

RQ Bio · Financing Record

Explore source-linked visual explanations for RQ Bio. Unsupported claims are withheld while source review continues.

Record 7426 · Recorded date: 2026-06-25

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime